Related Experiment Video
Updated: May 1, 2026

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes
Published on: May 1, 2021
A model-informed target product profile for population modification gene drives for malaria control
Agastya Mondal1, Héctor M Sánchez C1, John M Marshall1,2
1Divisions of Biostatistics & Epidemiology, School of Public Health, University of California, Berkeley, California, United States of America.
Gene drive mosquitoes show promise for malaria control. Modeling shows that fitness costs and effector gene efficacy are key to achieving a 50% reduction in malaria incidence within one year, lasting over three years.
Area of Science:
- Genetics and genomics
- Epidemiology
- Vector control
Background:
- Malaria transmission reduction in sub-Saharan Africa has stagnated.
- Gene drive-modified mosquitoes offer a novel approach for disease control.
- Target product profiles guide the development of gene drive technologies.
Purpose of the Study:
- To investigate parameter values for population modification gene drives.
- To assess if gene drives can achieve a 50% reduction in clinical malaria incidence for at least three years.
- To determine if gene drives can achieve a 50% reduction in clinical malaria incidence in under one year.
Main Methods:
- An eco-epidemiological model was used.
- Two African settings (Burkina Faso and Kenya) with varying transmission intensities were simulated.
- Key parameters explored included homing rates, resistance allele generation, fitness costs, and effector gene efficacy.
Main Results:
- Satisfying the "window-of-protection" criterion (≥3 years) also satisfied the "time-to-impact" criterion (<1 year).
- Fitness cost of the gene drive allele and effector gene efficacy were the most influential parameters.
- Low rates of functional resistance allele generation are preferred, while costly non-functional resistance alleles aid drive persistence.
Conclusions:
- Gene drive mosquito efficacy is primarily driven by fitness costs and effector gene performance.
- Existing homing rates in Anopheles gene drives are sufficient.
- A challenge for product readiness is that crucial efficacy parameters can only be reliably measured in field trials.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

